التفاصيل البيبلوغرافية
| العنوان: |
Pregnenolonyl-α-glucoside exhibits marked anti-cancer and CYP17A1 enzymatic inhibitory activities. |
| المؤلفون: |
Chou, Feng-Pai, Hsu, Wen-Chen, Huang, Sheng-Cih, Chang, Chin-Yuan, Chiou, Ya-Sheng, Tsai, Chia-Tse, Lyu, Jason WenJay, Chen, Wei-Ting, Wu, Tung-Kung |
| المصدر: |
Chemical Communications; 2/7/2020, Vol. 56 Issue 11, p1733-1736, 4p |
| مصطلحات موضوعية: |
BINDING site assay, GLYCOSIDES, BINDING sites, EXHIBITIONS |
| مستخلص: |
We report here that pregnenolonyl-α-glucoside (2), a steryl glycoside synthesized directly from pregnenolone and glucose via a consecutive multienzyme-catalyzed process, exhibits marked dose-dependent cytotoxic activity against HT29, AGS, and ES-2 cells with IC50 values of 23.5 to 50.9 μM. An in vitro CYP17A1 binding pattern assay and protein–ligand docking model support that 2, like abiraterone, binds in the active site heme iron pocket of CYP17A1. [ABSTRACT FROM AUTHOR] |
|
Copyright of Chemical Communications is the property of Royal Society of Chemistry and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
